Avis De Sécurité sur bio-rad lyphochek tumor marker plus and liquichek tumor marker, in the immulite 2000 / immulite 2000 xpi gi-ma series 312 and 313 tests

Polish data is current through November 2018. All of the data comes from the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Poland.